Skip to content
OpenCapital
Get started

Heron Therapeutics HRTX Q4 2024 Annual earnings

Reported February 27, 2025 · Before market open

Revenue$40.8MBeat by $4.1M
EPS$0.02Beat by $0.05
Revenue estimate$36.7M
EPS estimate-$0.03

Next report

Aug 10, 2026 (In 1 week)
Revenue estimate$42.2M
EPS estimate-$0.02

Versus estimates

Revenue

Q1 2026$34.7MMiss by $2.0MQ4 2025$40.6MBeat by $721.3KQ3 2025$38.2MMiss by $818.3KQ2 2025$37.2MMiss by $1.9MQ1 2025$38.9MBeat by $653.0K
Q4 2024$40.8MBeat by $4.1M

Diluted EPS

Q1 2026-$0.04Miss by $0.01Q4 2025-$0.02Beat by $0.01Q3 2025-$0.05Miss by $0.04Q2 2025-$0.02Miss by $0.01Q1 2025$0.01Beat by $0.02
Q4 2024$0.02Beat by $0.05

Ask the moment Heron Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Heron Therapeutics report Q4 2024 earnings?
Heron Therapeutics (HRTX) reported Q4 2024 earnings on February 27, 2025 before market open.
What were Heron Therapeutics's Q4 2024 revenue and EPS?
Heron Therapeutics reported revenue of $40.8M and eps of $0.02 for Q4 2024.
Did Heron Therapeutics beat estimates in Q4 2024?
Revenue beat the consensus estimate of $36.7M by $4.1M. EPS beat the consensus estimate of $-0.03 by $0.05.
Where can I find Heron Therapeutics's Q4 2024 SEC filings?
You can read the 10-K periodic report (0000950170-25-028374) directly on SEC EDGAR. The filing index links above go to sec.gov.